214 related articles for article (PubMed ID: 23561712)
1. Prospective randomized placebo-controlled study to assess the safety and efficacy of silodosin in the management of acute urinary retention.
Kumar S; Tiwari DP; Ganesamoni R; Singh SK
Urology; 2013 Jul; 82(1):171-5. PubMed ID: 23561712
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of Silodosin and Dutasteride Combination Therapy in Acute Urinary Retention due to Benign Prostatic Hyperplasia: A Single-Arm Prospective Study.
Hagiwara K; Koie T; Iwamura H; Imai A; Hatakeyama S; Yoneyama T; Hashimoto Y; Ohyama C
Biomed Res Int; 2016; 2016():4975851. PubMed ID: 27195288
[TBL] [Abstract][Full Text] [Related]
3. Management of acute urinary retention: a worldwide survey of 6074 men with benign prostatic hyperplasia.
Fitzpatrick JM; Desgrandchamps F; Adjali K; Gomez Guerra L; Hong SJ; El Khalid S; Ratana-Olarn K;
BJU Int; 2012 Jan; 109(1):88-95. PubMed ID: 22117624
[TBL] [Abstract][Full Text] [Related]
4. Alfuzosin 10 mg once daily increases the chances of successful trial without catheter after acute urinary retention secondary to benign prostate hyperplasia.
Tiong HY; Tibung MJ; Macalalag M; Li MK; Consigliere D
Urol Int; 2009; 83(1):44-8. PubMed ID: 19641358
[TBL] [Abstract][Full Text] [Related]
5. Individual patient data from registrational trials of silodosin in the treatment of non-neurogenic male lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH): subgroup analyses of efficacy and safety data.
Novara G; Chapple CR; Montorsi F
BJU Int; 2015 May; 115(5):802-14. PubMed ID: 25130493
[TBL] [Abstract][Full Text] [Related]
6. Factors predicting the success of a trial without catheter in acute urinary retention secondary to benign prostatic hyperplasia.
Bhomi KK; Bhattachan CL
Nepal Med Coll J; 2011 Sep; 13(3):178-81. PubMed ID: 22808810
[TBL] [Abstract][Full Text] [Related]
7. The management of acute urinary retention in France: a cross-sectional survey in 2618 men with benign prostatic hyperplasia.
Desgrandchamps F; De La Taille A; Doublet JD;
BJU Int; 2006 Apr; 97(4):727-33. PubMed ID: 16536763
[TBL] [Abstract][Full Text] [Related]
8. Does the duration of catheterization have an impact on the outcome of trial without catheter in patients with acute urine retention (AUR) due to benign prostatic hyperplasia (BPH)? A prospective randomized study.
Abuelnaga M; Elawady H; Mahmoud MA; Mostafa D; Samir M
Urologia; 2024 Feb; 91(1):107-111. PubMed ID: 38044812
[TBL] [Abstract][Full Text] [Related]
9. Alfuzosin 10 mg once daily in the management of acute urinary retention: results of a double-blind placebo-controlled study.
McNeill SA; Hargreave TB; Roehrborn CG;
Urology; 2005 Jan; 65(1):83-9; discussion 89-90. PubMed ID: 15667868
[TBL] [Abstract][Full Text] [Related]
10. Randomized controlled trial on the efficacy of bladder training before removing the indwelling urinary catheter in patients with acute urinary retention associated with benign prostatic hyperplasia.
Zhengyong Y; Changxiao H; Shibing Y; Caiwen W
Scand J Urol; 2014 Aug; 48(4):400-4. PubMed ID: 24697345
[TBL] [Abstract][Full Text] [Related]
11. Silodosin, a new alpha1A-adrenoceptor-selective antagonist for treating benign prostatic hyperplasia: results of a phase III randomized, placebo-controlled, double-blind study in Japanese men.
Kawabe K; Yoshida M; Homma Y;
BJU Int; 2006 Nov; 98(5):1019-24. PubMed ID: 16945121
[TBL] [Abstract][Full Text] [Related]
12. Role of combined use of ketoconazole and tamsulosin in management of acute urinary retention due to benign prostatic obstruction (a randomized controlled trial).
Elbendary M; El-Gamal OM; Soliman MG; Tawfik A; Taha MR
Prostate Cancer Prostatic Dis; 2013 Dec; 16(4):362-6. PubMed ID: 24018711
[TBL] [Abstract][Full Text] [Related]
13. Six-year follow up of silodosin monotherapy for the treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: What are the factors for continuation or withdrawal?
Yamanishi T; Kaga K; Fuse M; Shibata C; Kamai T; Uchiyama T
Int J Urol; 2015 Dec; 22(12):1143-8. PubMed ID: 26310102
[TBL] [Abstract][Full Text] [Related]
14. [Experience of the use of silodosin in acute urinary retention caused by benign prostatic hyperplasia].
Neĭmark AI; Nozdrachev NA
Urologiia; 2013; (4):47-8, 50-1. PubMed ID: 24159765
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of silodosin in comparison to tamsulosin in benign prostatic hyperplasia: a randomized controlled trial.
Pande S; Hazra A; Kundu AK
Indian J Pharmacol; 2014; 46(6):601-7. PubMed ID: 25538330
[TBL] [Abstract][Full Text] [Related]
16. Predictors of successful trial without catheter following acute urinary retention in benign prostatic enlargement: A single centre, multivariate analysis.
Bansal A; Arora A
Neurourol Urodyn; 2017 Sep; 36(7):1757-1762. PubMed ID: 28101889
[TBL] [Abstract][Full Text] [Related]
17. A pooled analysis of individual patient data from registrational trials of silodosin in the treatment of non-neurogenic male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH).
Novara G; Chapple CR; Montorsi F
BJU Int; 2014 Sep; 114(3):427-33. PubMed ID: 24571313
[TBL] [Abstract][Full Text] [Related]
18. Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in Europe.
Chapple CR; Montorsi F; Tammela TL; Wirth M; Koldewijn E; Fernández Fernández E;
Eur Urol; 2011 Mar; 59(3):342-52. PubMed ID: 21109344
[TBL] [Abstract][Full Text] [Related]
19. Non-inferiority of silodosin to tamsulosin in treating patients with lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH).
Yu HJ; Lin AT; Yang SS; Tsui KH; Wu HC; Cheng CL; Cheng HL; Wu TT; Chiang PH
BJU Int; 2011 Dec; 108(11):1843-8. PubMed ID: 21592295
[TBL] [Abstract][Full Text] [Related]
20. Prostate size influences the outcome after presenting with acute urinary retention.
McNeill AS; Rizvi S; Byrne DJ
BJU Int; 2004 Sep; 94(4):559-62. PubMed ID: 15329112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
